Vivos Therapeutics (VVOS) Misses Q2 EPS by 60c

Vivos Therapeutics (NASDAQ: VVOS) reported Q2 EPS of ($0.60). Revenue for the quarter came in at $4.1 million.

For earnings history and earnings-related data on Vivos Therapeutics (VVOS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders
• Nutrien warns shareholders about below-market mini-tender offer